img

Global Basal Insulin (Long-Acting Insulin) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Basal Insulin (Long-Acting Insulin) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Long-acting insulins are also called basal or background insulins. The role of basal insulin, also known as background insulin, is to keep blood glucose levels at consistent levels during periods of fasting. When fasting , the body steadily releases glucose into the blood to our cells supplied with energy.
Basal Insulin (Long-Acting Insulin) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Basal Insulin (Long-Acting Insulin) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Type 1 Diabetes and Type 2 Diabetes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Basal Insulin (Long-Acting Insulin) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Basal Insulin (Long-Acting Insulin) key manufacturers include Novo Nordisk, Sanofi Aventis, Eli Lilly, Biocon, Julphar, Exir, Sedico and Wockhardt, etc. Novo Nordisk, Sanofi Aventis, Eli Lilly are top 3 players and held % sales share in total in 2022.
Basal Insulin (Long-Acting Insulin) can be divided into Lantus, Levemir, Tresiba and Toujeo, etc. Lantus is the mainstream product in the market, accounting for % sales share globally in 2022.
Basal Insulin (Long-Acting Insulin) is widely used in various fields, such as Type 1 Diabetes and Type 2 Diabetes, etc. Type 1 Diabetes provides greatest supports to the Basal Insulin (Long-Acting Insulin) industry development. In 2022, global % sales of Basal Insulin (Long-Acting Insulin) went into Type 1 Diabetes filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Basal Insulin (Long-Acting Insulin) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novo Nordisk
Sanofi Aventis
Eli Lilly
Biocon
Julphar
Exir
Sedico
Wockhardt
Segment by Type
Lantus
Levemir
Tresiba
Toujeo
Basaglar
Biosimilar Glargines

Segment by Application


Type 1 Diabetes
Type 2 Diabetes

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Basal Insulin (Long-Acting Insulin) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Basal Insulin (Long-Acting Insulin), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Basal Insulin (Long-Acting Insulin) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Basal Insulin (Long-Acting Insulin) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Basal Insulin (Long-Acting Insulin) introduction, etc. Basal Insulin (Long-Acting Insulin) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Basal Insulin (Long-Acting Insulin) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Basal Insulin (Long-Acting Insulin) Market Overview
1.1 Basal Insulin (Long-Acting Insulin) Product Overview
1.2 Basal Insulin (Long-Acting Insulin) Market Segment by Type
1.2.1 Lantus
1.2.2 Levemir
1.2.3 Tresiba
1.2.4 Toujeo
1.2.5 Basaglar
1.2.6 Biosimilar Glargines
1.3 Global Basal Insulin (Long-Acting Insulin) Market Size by Type
1.3.1 Global Basal Insulin (Long-Acting Insulin) Market Size Overview by Type (2024-2034)
1.3.2 Global Basal Insulin (Long-Acting Insulin) Historic Market Size Review by Type (2024-2024)
1.3.3 Global Basal Insulin (Long-Acting Insulin) Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2024-2024)
1.4.2 Europe Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Breakdown by Type (2024-2024)
2 Global Basal Insulin (Long-Acting Insulin) Market Competition by Company
2.1 Global Top Players by Basal Insulin (Long-Acting Insulin) Sales (2024-2024)
2.2 Global Top Players by Basal Insulin (Long-Acting Insulin) Revenue (2024-2024)
2.3 Global Top Players by Basal Insulin (Long-Acting Insulin) Price (2024-2024)
2.4 Global Top Manufacturers Basal Insulin (Long-Acting Insulin) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Basal Insulin (Long-Acting Insulin) Market Competitive Situation and Trends
2.5.1 Basal Insulin (Long-Acting Insulin) Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Basal Insulin (Long-Acting Insulin) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2022)
2.7 Date of Key Manufacturers Enter into Basal Insulin (Long-Acting Insulin) Market
2.8 Key Manufacturers Basal Insulin (Long-Acting Insulin) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Basal Insulin (Long-Acting Insulin) Status and Outlook by Region
3.1 Global Basal Insulin (Long-Acting Insulin) Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Basal Insulin (Long-Acting Insulin) Historic Market Size by Region
3.2.1 Global Basal Insulin (Long-Acting Insulin) Sales in Volume by Region (2024-2024)
3.2.2 Global Basal Insulin (Long-Acting Insulin) Sales in Value by Region (2024-2024)
3.2.3 Global Basal Insulin (Long-Acting Insulin) Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Basal Insulin (Long-Acting Insulin) Forecasted Market Size by Region
3.3.1 Global Basal Insulin (Long-Acting Insulin) Sales in Volume by Region (2024-2034)
3.3.2 Global Basal Insulin (Long-Acting Insulin) Sales in Value by Region (2024-2034)
3.3.3 Global Basal Insulin (Long-Acting Insulin) Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Basal Insulin (Long-Acting Insulin) by Application
4.1 Basal Insulin (Long-Acting Insulin) Market Segment by Application
4.1.1 Type 1 Diabetes
4.1.2 Type 2 Diabetes
4.2 Global Basal Insulin (Long-Acting Insulin) Market Size by Application
4.2.1 Global Basal Insulin (Long-Acting Insulin) Market Size Overview by Application (2024-2034)
4.2.2 Global Basal Insulin (Long-Acting Insulin) Historic Market Size Review by Application (2024-2024)
4.2.3 Global Basal Insulin (Long-Acting Insulin) Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application (2024-2024)
4.3.2 Europe Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Breakdown by Application (2024-2024)
5 North America Basal Insulin (Long-Acting Insulin) by Country
5.1 North America Basal Insulin (Long-Acting Insulin) Historic Market Size by Country
5.1.1 North America Basal Insulin (Long-Acting Insulin) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Basal Insulin (Long-Acting Insulin) Sales in Volume by Country (2024-2024)
5.1.3 North America Basal Insulin (Long-Acting Insulin) Sales in Value by Country (2024-2024)
5.2 North America Basal Insulin (Long-Acting Insulin) Forecasted Market Size by Country
5.2.1 North America Basal Insulin (Long-Acting Insulin) Sales in Volume by Country (2024-2034)
5.2.2 North America Basal Insulin (Long-Acting Insulin) Sales in Value by Country (2024-2034)
6 Europe Basal Insulin (Long-Acting Insulin) by Country
6.1 Europe Basal Insulin (Long-Acting Insulin) Historic Market Size by Country
6.1.1 Europe Basal Insulin (Long-Acting Insulin) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Basal Insulin (Long-Acting Insulin) Sales in Volume by Country (2024-2024)
6.1.3 Europe Basal Insulin (Long-Acting Insulin) Sales in Value by Country (2024-2024)
6.2 Europe Basal Insulin (Long-Acting Insulin) Forecasted Market Size by Country
6.2.1 Europe Basal Insulin (Long-Acting Insulin) Sales in Volume by Country (2024-2034)
6.2.2 Europe Basal Insulin (Long-Acting Insulin) Sales in Value by Country (2024-2034)
7 Asia-Pacific Basal Insulin (Long-Acting Insulin) by Region
7.1 Asia-Pacific Basal Insulin (Long-Acting Insulin) Historic Market Size by Region
7.1.1 Asia-Pacific Basal Insulin (Long-Acting Insulin) Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Basal Insulin (Long-Acting Insulin) Forecasted Market Size by Region
7.2.1 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales in Value by Region (2024-2034)
8 Latin America Basal Insulin (Long-Acting Insulin) by Country
8.1 Latin America Basal Insulin (Long-Acting Insulin) Historic Market Size by Country
8.1.1 Latin America Basal Insulin (Long-Acting Insulin) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Basal Insulin (Long-Acting Insulin) Sales in Volume by Country (2024-2024)
8.1.3 Latin America Basal Insulin (Long-Acting Insulin) Sales in Value by Country (2024-2024)
8.2 Latin America Basal Insulin (Long-Acting Insulin) Forecasted Market Size by Country
8.2.1 Latin America Basal Insulin (Long-Acting Insulin) Sales in Volume by Country (2024-2034)
8.2.2 Latin America Basal Insulin (Long-Acting Insulin) Sales in Value by Country (2024-2034)
9 Middle East and Africa Basal Insulin (Long-Acting Insulin) by Country
9.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Historic Market Size by Country
9.1.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Forecasted Market Size by Country
9.2.1 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Novo Nordisk Basal Insulin (Long-Acting Insulin) Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 Sanofi Aventis
10.2.1 Sanofi Aventis Company Information
10.2.2 Sanofi Aventis Introduction and Business Overview
10.2.3 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Sanofi Aventis Basal Insulin (Long-Acting Insulin) Products Offered
10.2.5 Sanofi Aventis Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Eli Lilly Basal Insulin (Long-Acting Insulin) Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Biocon
10.4.1 Biocon Company Information
10.4.2 Biocon Introduction and Business Overview
10.4.3 Biocon Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Biocon Basal Insulin (Long-Acting Insulin) Products Offered
10.4.5 Biocon Recent Development
10.5 Julphar
10.5.1 Julphar Company Information
10.5.2 Julphar Introduction and Business Overview
10.5.3 Julphar Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Julphar Basal Insulin (Long-Acting Insulin) Products Offered
10.5.5 Julphar Recent Development
10.6 Exir
10.6.1 Exir Company Information
10.6.2 Exir Introduction and Business Overview
10.6.3 Exir Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Exir Basal Insulin (Long-Acting Insulin) Products Offered
10.6.5 Exir Recent Development
10.7 Sedico
10.7.1 Sedico Company Information
10.7.2 Sedico Introduction and Business Overview
10.7.3 Sedico Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Sedico Basal Insulin (Long-Acting Insulin) Products Offered
10.7.5 Sedico Recent Development
10.8 Wockhardt
10.8.1 Wockhardt Company Information
10.8.2 Wockhardt Introduction and Business Overview
10.8.3 Wockhardt Basal Insulin (Long-Acting Insulin) Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Wockhardt Basal Insulin (Long-Acting Insulin) Products Offered
10.8.5 Wockhardt Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Basal Insulin (Long-Acting Insulin) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Basal Insulin (Long-Acting Insulin) Industrial Chain Analysis
11.4 Basal Insulin (Long-Acting Insulin) Market Dynamics
11.4.1 Basal Insulin (Long-Acting Insulin) Industry Trends
11.4.2 Basal Insulin (Long-Acting Insulin) Market Drivers
11.4.3 Basal Insulin (Long-Acting Insulin) Market Challenges
11.4.4 Basal Insulin (Long-Acting Insulin) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Basal Insulin (Long-Acting Insulin) Distributors
12.3 Basal Insulin (Long-Acting Insulin) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Lantus
Table 2. Major Company of Levemir
Table 3. Major Company of Tresiba
Table 4. Major Company of Toujeo
Table 5. Major Company of Basaglar
Table 6. Major Company of Biosimilar Glargines
Table 7. Global Basal Insulin (Long-Acting Insulin) Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 8. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2024-2024) & (K Units)
Table 9. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Type (2024-2024)
Table 10. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2024-2024) & (US& Million)
Table 11. Global Basal Insulin (Long-Acting Insulin) Market Share in Value by Type (2024-2024)
Table 12. Global Basal Insulin (Long-Acting Insulin) Price by Type (2024-2024) & (US$/Unit)
Table 13. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2024-2034) & (K Units)
Table 14. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Type (2024-2034)
Table 17. Global Basal Insulin (Long-Acting Insulin) Price by Type (2024-2034) & (US$/Unit)
Table 18. North America Basal Insulin (Long-Acting Insulin) Sales by Type (2024-2024) & (K Units)
Table 19. North America Basal Insulin (Long-Acting Insulin) Sales by Type (2024-2024) & (US$ Million)
Table 20. Europe Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2024-2024)
Table 21. Europe Basal Insulin (Long-Acting Insulin) Sales by Type (2024-2024) & (US$ Million)
Table 22. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2024-2024)
Table 23. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Type (2024-2024) & (US$ Million)
Table 24. Latin America Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2024-2024)
Table 25. Latin America Basal Insulin (Long-Acting Insulin) Sales by Type (2024-2024) & (US$ Million)
Table 26. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales (K Units) by Type (2024-2024)
Table 27. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Type (2024-2024) & (US$ Million)
Table 28. Global Basal Insulin (Long-Acting Insulin) Sales by Company (2024-2024) & (K Units)
Table 29. Global Basal Insulin (Long-Acting Insulin) Sales Share by Company (2024-2024)
Table 30. Global Basal Insulin (Long-Acting Insulin) Revenue by Company (2024-2024) & (US$ Million)
Table 31. Global Basal Insulin (Long-Acting Insulin) Revenue Share by Company (2024-2024)
Table 32. Global Market Basal Insulin (Long-Acting Insulin) Price by Company (2024-2024) & (US$/Unit)
Table 33. Global Basal Insulin (Long-Acting Insulin) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Basal Insulin (Long-Acting Insulin) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Basal Insulin (Long-Acting Insulin) as of 2022)
Table 36. Date of Key Manufacturers Enter into Basal Insulin (Long-Acting Insulin) Market
Table 37. Key Manufacturers Basal Insulin (Long-Acting Insulin) Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Basal Insulin (Long-Acting Insulin) Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 40. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2024-2024) & (K Units)
Table 41. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Region (2024-2024)
Table 42. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2024-2024) & (US$ Million)
Table 43. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Region (2024-2024)
Table 44. Global Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 45. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2024-2034) & (K Units)
Table 46. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Basal Insulin (Long-Acting Insulin) Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Region (2024-2034)
Table 49. Global Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 50. Global Basal Insulin (Long-Acting Insulin) Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 51. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2024) & (K Units)
Table 52. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Application (2024-2024)
Table 53. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2024) & (US$ Million)
Table 54. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Application (2024-2024)
Table 55. Global Basal Insulin (Long-Acting Insulin) Price by Application (2024-2024) & (US$/Unit)
Table 56. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2034) & (K Units)
Table 57. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Application (2024-2034)
Table 60. Global Basal Insulin (Long-Acting Insulin) Price by Application (2024-2034) & (US$/Unit)
Table 61. North America Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2024) (K Units)
Table 62. North America Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2024) & (US$ Million)
Table 63. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2024) (K Units)
Table 64. Europe Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2024) & (US$ Million)
Table 65. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2024) (K Units)
Table 66. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2024) & (US$ Million)
Table 67. Latin America Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2024) (K Units)
Table 68. Latin America Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2024) & (US$ Million)
Table 69. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2024) (K Units)
Table 70. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2024) & (US$ Million)
Table 71. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2024) & (K Units)
Table 72. North America Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Country (2024-2024)
Table 73. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2024) & (US$ Million)
Table 74. North America Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Country (2024-2024)
Table 75. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2034) & (K Units)
Table 76. North America Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2024) & (K Units)
Table 80. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Country (2024-2024)
Table 81. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2024) & (US$ Million)
Table 82. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Country (2024-2024)
Table 83. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2034) & (K Units)
Table 84. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2024-2024) & (K Units)
Table 88. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Region (2024-2024)
Table 89. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2024-2024) & (US$ Million)
Table 90. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Region (2024-2024)
Table 91. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2024-2034) & (K Units)
Table 92. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2024) & (K Units)
Table 96. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Country (2024-2024)
Table 97. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2024) & (US$ Million)
Table 98. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Country (2024-2024)
Table 99. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2034) & (K Units)
Table 100. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2024) & (K Units)
Table 104. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Country (2024-2024)
Table 105. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2024) & (US$ Million)
Table 106. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Country (2024-2024)
Table 107. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2034) & (K Units)
Table 108. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Country (2024-2034)
Table 111. Novo Nordisk Company Information
Table 112. Novo Nordisk Introduction and Business Overview
Table 113. Novo Nordisk Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 114. Novo Nordisk Basal Insulin (Long-Acting Insulin) Product
Table 115. Novo Nordisk Recent Development
Table 116. Sanofi Aventis Company Information
Table 117. Sanofi Aventis Introduction and Business Overview
Table 118. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 119. Sanofi Aventis Basal Insulin (Long-Acting Insulin) Product
Table 120. Sanofi Aventis Recent Development
Table 121. Eli Lilly Company Information
Table 122. Eli Lilly Introduction and Business Overview
Table 123. Eli Lilly Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 124. Eli Lilly Basal Insulin (Long-Acting Insulin) Product
Table 125. Eli Lilly Recent Development
Table 126. Biocon Company Information
Table 127. Biocon Introduction and Business Overview
Table 128. Biocon Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 129. Biocon Basal Insulin (Long-Acting Insulin) Product
Table 130. Biocon Recent Development
Table 131. Julphar Company Information
Table 132. Julphar Introduction and Business Overview
Table 133. Julphar Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 134. Julphar Basal Insulin (Long-Acting Insulin) Product
Table 135. Julphar Recent Development
Table 136. Exir Company Information
Table 137. Exir Introduction and Business Overview
Table 138. Exir Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 139. Exir Basal Insulin (Long-Acting Insulin) Product
Table 140. Exir Recent Development
Table 141. Sedico Company Information
Table 142. Sedico Introduction and Business Overview
Table 143. Sedico Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 144. Sedico Basal Insulin (Long-Acting Insulin) Product
Table 145. Sedico Recent Development
Table 146. Wockhardt Company Information
Table 147. Wockhardt Introduction and Business Overview
Table 148. Wockhardt Basal Insulin (Long-Acting Insulin) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 149. Wockhardt Basal Insulin (Long-Acting Insulin) Product
Table 150. Wockhardt Recent Development
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Basal Insulin (Long-Acting Insulin) Market Trends
Table 154. Basal Insulin (Long-Acting Insulin) Market Drivers
Table 155. Basal Insulin (Long-Acting Insulin) Market Challenges
Table 156. Basal Insulin (Long-Acting Insulin) Market Restraints
Table 157. Basal Insulin (Long-Acting Insulin) Distributors List
Table 158. Basal Insulin (Long-Acting Insulin) Downstream Customers
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Basal Insulin (Long-Acting Insulin) Product Picture
Figure 2. Global Basal Insulin (Long-Acting Insulin) Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Basal Insulin (Long-Acting Insulin) Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Basal Insulin (Long-Acting Insulin) Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Lantus
Figure 6. Global Lantus Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Levemir
Figure 8. Global Levemir Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Tresiba
Figure 10. Global Tresiba Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Toujeo
Figure 12. Global Toujeo Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Basaglar
Figure 14. Global Basaglar Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Product Picture of Biosimilar Glargines
Figure 16. Global Biosimilar Glargines Sales YoY Growth (2024-2034) & (K Units)
Figure 17. Global Basal Insulin (Long-Acting Insulin) Sales by Type (2024-2034) & (US$ Million)
Figure 18. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Type in 2022 & 2034
Figure 19. North America Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Type in 2022
Figure 20. North America Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Type in 2022
Figure 21. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Type in 2022
Figure 22. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Type in 2022
Figure 25. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Basal Insulin (Long-Acting Insulin) Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Basal Insulin (Long-Acting Insulin) Revenue in 2022
Figure 31. Basal Insulin (Long-Acting Insulin) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 32. Product Picture of Type 1 Diabetes
Figure 33. Global Type 1 Diabetes Sales YoY Growth (2024-2034) & (K Units)
Figure 34. Product Picture of Type 2 Diabetes
Figure 35. Global Type 2 Diabetes Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Global Basal Insulin (Long-Acting Insulin) Sales by Application (2024-2034) & (US$ Million)
Figure 37. Global Basal Insulin (Long-Acting Insulin) Sales Market Share by Application in 2022 & 2034
Figure 38. North America Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Application in 2022
Figure 39. North America Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Application in 2022
Figure 40. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Application in 2022
Figure 41. Europe Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Application in 2022
Figure 44. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Basal Insulin (Long-Acting Insulin) Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Basal Insulin (Long-Acting Insulin) Manufacturing Cost Structure
Figure 49. Basal Insulin (Long-Acting Insulin) Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries